In situ hybridization for gastrin-releasing peptide receptor (GRP receptor) expression in prostatic carcinoma

International Journal of Cancer

Volumn 79, Issue 1, 1998, Pages 82-90

  Bartholdi, Marty F ^a   Wu, James M ^a   Pu, Haifeng ^a,b   Troncoso, Patricia ^c   Eden, Peter A ^d,e   Feldman, Richard I ^a  

^a BAYER AG   (Germany)

^b H LUNDBECK A S   (Denmark)

^c UNIVERSITY OF TEXAS   (United States)

^d Biomeasure Inc   (United States)

^e JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOMBESIN RECEPTOR; GASTRIN RELEASING PEPTIDE; HORMONE RECEPTOR; MESSENGER RNA; NEUROMEDIN B;

ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

GASTRIN-RELEASING PEPTIDE; HUMANS; IN SITU HYBRIDIZATION; MALE; NEUROKININ B; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RADIOLIGAND ASSAY; RECEPTORS, BOMBESIN; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0032548868     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980220)79:1<82::AID-IJC16>3.0.CO;2-J     Document Type: Article

References (20)

1. APRIKIAN, A.., CORDON-CARDO, C., FAIR, W.R. and REUTER, V.E., Caracterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer, 71, 3952-3965 (1993).
2. APRIKIAN, A.C., HAN, K., CHEVALIER, S., BAZINET, M. and VIALLET, J., Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells, J. Mol. Endocrinol., 16, 297-306 (1996).
3. BOLOGNA, M.C., FESTUCCIA, C., MUZI, P., BIORDI, L. and CIOMEI, C., Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer, 63, 1714-1720 (1989).
4. BRIGATI, D.J., BRUGEON, L.R. and UNGER, E.R., Immunocytochemistry is automated: the development of a robotic workstation based on the capillary action principle. J. Histotechnol., 11, 165-183 (1993).
5. CARNEY, D.N., CUTTITTA, F., MOODY, T.W. and MINNA, J.D., Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide. Cancer Res., 47, 821-825 (1987).
6. GOHEN, M.K., ARBER, D.A., COFFIELD, K.S., KEEGAN, G.T., MCCLINTOCK, J. and SPEIGHTS, JR., V.O., Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression. Cancer, 74, 1899-1903 (1994).
7. COHEN, R.J., GLEZERSON, G. and HAFFEJEE, Z., Neuroendocrine cells, a new prognostic parameter in prostate cancer. Brit. J. Urol., 68, 258-262 (1991).
8. COTTREZ, F., AURIAULT, C., CAPRON, A. and GROUX, H., Quantitative PCR: validation of the use of a multispecific internal control. Nucleic Acids Res., 22, 2712-2713 (1994).
9. DI SANT' AGNESE, P.A., Calcitoninlike immunoreactive and bombesinlike immunoreactive endocrine-paracrine cells of the human prostate. Arch. Pathol. Lab. Med., 110, 412-415 (1986).
10. DI SANT'AGNESE, P.A., Neuroendocrine differentiation in carcinoma of the prostate. Cancer (Suppl.), 70, 254-268 (1992).
11. ERSPAMER, V., Discovery, isolation, and characterization of bombesin-like peptides. Ann. N.Y. Acad. Sci., 547, 3-9 (1988).
12. FELDMAN, R.I., BARTHOLDI, M.F. and WU, J.M., Bombesin-like peptide receptor subtypes promote mitogenesis which requires persistent receptor signaling. Mol. Pharmacol., 50, 1346-1354 (1996).
13. GRAYSON, D.R., VOVOLIN, P. and SANTI, M.-R., Absolute quantitation of gamma-aminobutyric acid A receptor subunit messenger RNAs by competitive polymerase chain reaction. In: P.M. Conn (ed.). Methods in Neurosciences, Vol. 12, pp. 191-208 Academic Press, San Diego (1993).
14. HOOSEIN, N.M., LOGOTHETIS, C.J. and CHUNG, L.W., Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide arid somatostatin analog RC-160 on, the invasive capacity of human prostatic carcinoma cells. J. Urol., 149, 1209-1213 (1993).
15. LEBACQ-VERHEYDEN, A.M., TREPEL, A.M., SAUSVILLE, E.A. and BATTEY, J.F., Bombesin and gastrin releasing peptide: neuropeptides, secretagogues, and growth factors. Handbook exp. Pharmacol., 95, 71-124 (1990).
16. LOGOTHETIS, C. and HOOSEIN, N., The inhibition of the paracrine progression of prostate cancer as an approach to early therapy of prostatic carcinoma. J. Cell Biochem. (Suppl.), 16h, 128-134 (1992).
17. MILOVANOVIC, S.R., RADULOVIC, S., GROOT, K. and SCHALLY, A.V., Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160. Prostate, 20, 269-280 (1992).
18. PINSKI, J., REILE, H., HALMOS, G., GROOT, K. and SCHALLY, A.V., Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing. peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer. Cancer Res., 54, 169-174 (1994).
19. REILE, H., ARMATIS, P.E. and SCHALLY, A.V., Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells. Prostate, 25, 29-38 (1994).
20. WU, J.M., HOANG, D.O. and FELDMAN, R.I., Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs. Mol. Pharmacol., 47, 871-881 (1995).